Thursday, 23 November 2017 - 14:54

Top stories

News of the week

Novo Nordisk discloses ambitious development plans for obesity drugs

Denmark-based Novo Nordisk yesterday announced at a meeting with investors that it plans to conduct a Phase-III PIONEER clinical trial with as many as 4,500 patients with obesity, assessing the investigational drug semaglutide (NN9536). The decision reflects the highly positive…

M&A drive in pharma fading

Approvals

Procedures / New drug and device authorizations / Recommendations

Momentous week for cancer sector: important announcements and approvals

A week of important news for cancer industry has just ended. The vaccine that Moderna Therapeutics is co-developing with Merck & Co. has been administered to a patient for the first time, within a Phase I clinical trial. The vaccine…

Companies

Healthcare market news

Novo Nordisk discloses ambitious development plans for obesity drugs

Denmark-based Novo Nordisk yesterday announced at a meeting with investors that it plans to conduct a Phase-III PIONEER clinical trial with as many as 4,500 patients with obesity, assessing the investigational drug semaglutide (NN9536). The decision reflects the highly positive…

Chemistry

Market and Technology

AkzoNobel confirms ongoing talks with Axalta

AkzoNobel today confirmed in a press release it has talks underway with competitor Axalta Coating, aimed at a merger of equals between the two coating giants. The merger would result in lower prices for raw materials, which would generate significant…

M&A

Mergers & Acquisitions

M&A drive in pharma fading

Deals in pharma M&A in the first 9 months of the year totaled $66.4bn, equaling a 36% drop as compared to 2016. The decrease is even more significant when compared to 2015, when sales volume over the first three quarters…

Nutraceuticals

Food supplements

Asthma, evidences of benefit from vitamin D in The Lancet Respiratory Medicine

The review The Lancet Respiratory Medicine has reported the results from a research conducted by the Queen Mary University of London, demonstrating that oral vitamin D, associated to the standard therapy for asthma, can help halve the risk of asthma…

Pathology

Latest developments

Can a genetic mutation protect from diabetes?

Results from a study establishing a link between a genetic mutation, a reduction in diabetes cases and lower glycaemia levels in fasting patients have been published on Science Advances. Some researchers at Northwestern University Feinberg School of Medicine, Chicago, have…

Safety

News on Product Safety

FDA issues warning about Intercept’s Ocaliva after 19 patients died

The FDA has officially warned doctors about the risks from Intercept Pharmaceuticals’ Ocaliva (obeticholic acid), after 19 patients on Intercept’s drug, developed to treat PBC (Primary Biliary Cholangitis) had died. The FDA, anyway, has specified that the deaths have occurred…

Trials

Preclinical Trials / Clinical Trials / Epidemiology

Can a genetic mutation protect from diabetes?

Results from a study establishing a link between a genetic mutation, a reduction in diabetes cases and lower glycaemia levels in fasting patients have been published on Science Advances. Some researchers at Northwestern University Feinberg School of Medicine, Chicago, have…